pregnane-20-one has been researched along with Post-Natal Depression in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ackley, MA; Althaus, AL; Bai, Z; Belfort, GM; Beresis, RT; Blanco, MJ; Dai, J; Doherty, JJ; Grossman, SJ; Harrison, BL; Hoffmann, E; Loya, CM; Martinez Botella, G; Robichaud, AJ; Salituro, FG | 1 |
1 other study(ies) available for pregnane-20-one and Post-Natal Depression
Article | Year |
---|---|
Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)
Topics: Allosteric Regulation; Animals; Depression, Postpartum; Depressive Disorder, Major; Female; GABA-A Receptor Agonists; Mice; Pregnanolone; Pyrazoles; Rats; Receptors, GABA-A | 2017 |